These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9315421)

  • 1. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
    Ghosh D; Nayak NR; Sengupta J
    Contraception; 1997 Aug; 56(2):117-22. PubMed ID: 9315421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey.
    Nayak NR; Ghosh D; Lasley BL; Sengupta J
    Contraception; 1997 Feb; 55(2):103-14. PubMed ID: 9071520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
    Nayak NR; Sengupta J; Ghosh D
    Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O; Gordon K; Williams RF; Hodgen GD
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early luteal phase administration of mifepristone inhibits preimplantation embryo development and viability in the rhesus monkey.
    Ghosh D; Kumar PG; Sengupta J
    Hum Reprod; 1997 Mar; 12(3):575-82. PubMed ID: 9130762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
    Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
    Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M
    Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preimplantation embryo morphology following early luteal phase anti-nidatory treatment with mifepristone (RU486) in the rhesus monkey.
    Ghosh D; Lalitkumar PG; Wong VJ; Hendrickx AG; Sengupta J
    Hum Reprod; 2000 Jan; 15(1):180-8. PubMed ID: 10611210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility impairment after mifepristone treatment to rats at proestrus. Actions on the hypothalamic-hypophyseal-ovarian axis.
    Telleria CM; Mezzadri MR; Deis RP
    Contraception; 1997 Oct; 56(4):267-74. PubMed ID: 9408709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-implantation activity of antiestrogens and mifepristone.
    Dao B; Vanage G; Marshall A; Bardin CW; Koide SS
    Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of Le(y) oligosaccharide in endometrium during menstrual cycle and effect of early luteal phase mifepristone administration on its expression in implantation stage endometrium of the rhesus monkey.
    Ghosh D; Liu N; Zhu ZM; Sengupta J
    Hum Reprod; 1998 May; 13(5):1374-9. PubMed ID: 9647575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey.
    Ghosh D; Sengupta J
    Hum Reprod; 1993 Apr; 8(4):552-8. PubMed ID: 8501184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteal phase contraception with mifepristone (RU 486) in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):17-22. PubMed ID: 8132238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations.
    Gemzell-Danielsson K; Hamberg M
    Hum Reprod; 1994 Sep; 9(9):1626-30. PubMed ID: 7836511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.